相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration
Willi Cawello et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2016)
Pharmacokinetic Properties and Tolerability of Rotigotine Transdermal Patch After Repeated-Dose Application in Healthy Korean Volunteers
Bo-Hyung Kim et al.
CLINICAL THERAPEUTICS (2015)
Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
Willi Cawello et al.
CLINICAL DRUG INVESTIGATION (2014)
An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment
Diego Garcia-Borreguero et al.
CURRENT OPINION IN NEUROLOGY (2014)
Predictors of quality of life in people with Parkinson's disease: evidence for both domain specific and general relationships
Jane Simpson et al.
DISABILITY AND REHABILITATION (2014)
Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine
Willi Cawello et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2014)
Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
Gordon W. Duncan et al.
MOVEMENT DISORDERS (2014)
No Influence of the CYP2C19-Selective Inhibitor Omeprazole on the Pharmacokinetics of the Dopamine Receptor Agonist Rotigotine
Jan-Peer Elshoff et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2014)
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease
Nir Giladi et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group
Diego Garcia-Borreguero et al.
SLEEP MEDICINE (2013)
Review: management of Parkinson's disease
David J Pedrosa et al.
Neuropsychiatric Disease and Treatment (2013)
Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function
Willi Cawello et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies
Jan-Peer Elshoff et al.
CLINICAL THERAPEUTICS (2012)
Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
Yoland Smith et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome
S. R. Schreglmann et al.
PARKINSONISM & RELATED DISORDERS (2012)
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension study
Lawrence W. Elmer et al.
PARKINSONISM & RELATED DISORDERS (2012)
Rotigotine Transdermal Patch A Review of its Use in the Treatment of Parkinson's Disease
Mark Sanford et al.
CNS DRUGS (2011)
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
Wolfgang Oertel et al.
LANCET NEUROLOGY (2011)
Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, Placebo-Controlled Study (RECOVER)
Claudia Trenkwalder et al.
MOVEMENT DISORDERS (2011)
Milestones in Parkinson's Disease Therapeutics
Olivier Rascol et al.
MOVEMENT DISORDERS (2011)
Continuous Dopaminergic Stimulation
Maria Cruz Rodriguez-Oroz et al.
NEUROLOGIST (2011)
Hypersexuality and compulsive over-eating associated with transdermal dopamine agonist therapy
Claire Hinnell et al.
PARKINSONISM & RELATED DISORDERS (2011)
Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study
Birgit Hoegl et al.
JOURNAL OF NEUROLOGY (2010)
The clinical spectrum of levodopa-induced motor complications
E. Hametner et al.
JOURNAL OF NEUROLOGY (2010)
Rotigotine Improves Restless Legs Syndrome: A 6-Month Randomized, Double-Blind, Placebo-Controlled Trial in the United States
Wayne A. Hening et al.
MOVEMENT DISORDERS (2010)
Restless legs syndrome: pathophysiology, clinical presentation and management
Claudia Trenkwalder et al.
NATURE REVIEWS NEUROLOGY (2010)
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study
Wolfgang H. Oertel et al.
SLEEP MEDICINE (2010)
ROTIGOTINE TRANSDERMAL PATCH FOR THE TREATMENT OF PARKINSON'S DISEASE AND RESTLESS LEGS SYNDROME
B. Boroojerdi et al.
DRUGS OF TODAY (2010)
Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine
Marina Braun et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive
Marina Braun et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction
K. A. Stockwell et al.
EXPERIMENTAL NEUROLOGY (2009)
Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa
Marina Braun et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease
Dieter Scheller et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Absorption, Disposition, Metabolic Fate, and Elimination of the Dopamine Agonist Rotigotine in Man: Administration by Intravenous Infusion or Transdermal Delivery
Willi Cawello et al.
DRUG METABOLISM AND DISPOSITION (2009)
Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine
M. Malik et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Speech treatment for Parkinson’s disease
Lorraine O Ramig et al.
Expert Review of Neurotherapeutics (2008)
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements
Werner J. Schmidt et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome:: a randomised, double-blind, placebo-controlled trial
Claudia Trenkwalder et al.
LANCET NEUROLOGY (2008)
Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole
Nir Giladi et al.
MOVEMENT DISORDERS (2007)
Diagnostic standards for dopaminergic augmentation of restless legs syndrome:: Report from a World Association of Sleep Medicine -: International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute
Diego Garcia-Borreguero et al.
SLEEP MEDICINE (2007)
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
Werner H. Poewe et al.
LANCET NEUROLOGY (2007)
Transdermal rotigotine - Double-blind, placebo-controlled trial in Parkinson disease
Joseph Jankovic et al.
ARCHIVES OF NEUROLOGY (2007)
Advanced Parkinson disease treated with rotigotine transdermal system - PREFER Study
Peter A. LeWitt et al.
NEUROLOGY (2007)
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
R. L. Watts et al.
NEUROLOGY (2007)
Transdermal administration of radiolabelled [14C]rotigotine by a patch formulation -: A mass balance trial
Willi Cawello et al.
CLINICAL PHARMACOKINETICS (2007)
Rotigotine transdermal patch enables rapid titration to effective doses in advanced-stage idiopathic Parkinson disease:: Subanalysis of a parallel group, open-label, dose-escalation study
Tomislav Babic et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Sex and the risk of restless legs syndrome in the general population
K Berger et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Incidence of Parkinson's disease: Variation by age, gender, and Race/Ethnicity
SK Van Den Eeden et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
MJ Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Family history study of the restless legs syndrome
R. P. Allen et al.
SLEEP MEDICINE (2002)
What contributes to quality of life in patients with Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
分享论文
